Kaveri Seed CompanyQ3 FY24

Kaveri Seed Company Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹728.05P/E: 14.7Market Cap: ₹3.8K CrSector: Agricultural Food & other Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • Company expects overall growth of 12% to 15% annually over the next 5 to 7 years.
  • Non-cotton segment, contributing 65%-70% of revenues, is set to grow at 15%-20%.
  • Cotton is expected to contribute around 30%-35% of revenue with potential to regain market share.
  • Focus on 4 key crops: cotton, maize, rice, and vegetables which will deliver majority of future growth.
  • R&D and infrastructure investments made over past 5-7 years will translate to revenue growth in next 5-10 years.
  • Export revenues are expected to grow substantially, potentially crossing Rs. 100 crore over 3-4 years.
  • Vegetable segment targeted for 20%-25% annual growth over next 5 years.
  • Market share gains anticipated in maize and hybrid rice via new product pipelines.
  • Overall revenue target is Rs. 2,000 crore by FY2030 from current ~Rs. 1,150 crore.

See what Kaveri Seed Company management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no mention of any current or planned fundraising through debt or equity in the provided transcript.
  • The management discussed increased investments in R&D, infrastructure, and employee costs, but these appear to be funded from internal accruals or existing resources.
  • The company has announced a buyback of shares, indicating surplus cash and no immediate need for equity fundraising.
  • There is mention of investments related to inventory buildup and farmer payments but no explicit reference to raising new debt.
  • Overall, no specific plans for raising capital via debt or equity are disclosed in the transcript.

See what Kaveri Seed Company management said on order book — free account, 30 seconds.

Capex plans

Yes
  • The company has significantly increased its R&D spend and infrastructure over the past 5 to 7 years, which is expected to translate into revenue growth over the next 5 to 10 years.
  • Employee costs have doubled or tripled since 2014-15, primarily due to increased R&D headcount, which is now close to 200.
  • R&D expenditure is currently around 5% of sales and is expected to rise to 8%-9%, including capital expenditure.
  • Investments have been made in building inventory and farmer payments, indicating ongoing working capital requirements.
  • The company is focused on expanding its portfolio in key crops (cotton, maize, rice, and vegetables) with a strong pipeline of hybrids being trialed.
  • No specific mention of new strategic investments or large-scale capital expenditure was made, but overall infrastructure and R&D development suggest steady capital infusion in these areas.

Track Kaveri Seed Company — get its next earnings analysis in your feed

How does Kaveri Seed Company rank vs peers in Agricultural Food & other Products?

Pro feature
ThisKaveri Seed Company
Rev 3Mar 3

How does Kaveri Seed Company rank in Agricultural Food & other Products?

Compare Kaveri Seed Company against every Agricultural Food & other Products company (Q3 FY24) on revenue, margins and earnings-call signals.

View Agricultural Food & other Products leaderboard →

Others in Agricultural Food & other Products this season

  • Rana Sugars (Q2 FY27)

    . Key results statement takeaways from Rana Sugars Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

  • Kohinoor Foods (Q2 FY27)

    EBITDA for the quarter ended September 30, 2026, is reported as ₹44 crore, a 13% year-on-year increase from ₹39 crore. Key results statement takeaways from Kohi

  • NFP Sampoorna (Q2 FY27)

    Revenue from Operations for the half-year ended September 30, 2026: ₹253,834.309 thousand (Standalone), ₹253,834.309 thousand (Consolidated). Key results statem

  • M K Proteins (Q2 FY27)

    Revenue from operations for the quarter ended 30th September 2026: ₹4446.28 Lakhs . Key results statement takeaways from M K Proteins Ltd's Q2 FY27 results stat

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →